Fidelity Disruptive Technology ETF (FDTX)
NASDAQ (NGS) NASDAQ (NGS) Primary 
FDTX: Solid Way To Play AI
Fidelity Disruptive Technology ETF (FDTX) earns a Buy for its concentrated, actively managed exposure to leading AI infrastructure and compute names. FDTX's top holdings—TSM, NVDA, MSFT, AMZN, GOOG, META—anchor it at the upper end of the AI value chain, driving recent outperformance. The fund's 0.50% expense ratio is competitive for active management, and its 42% turnover signals disciplined, thesis-driven portfolio construction.
Fidelity Disruptive Technology ETF Is Down 12% in 2026 and This Catalyst Could Decide What Comes Next
If you searched for a biotech or health sciences ETF and landed on Fidelity Disruptive Technology ETF (NYSEARCA:FDTX), there is something important to clarify upfront: this fund carries zero healthcare sector exposure.
Regulatory Shifts Warrant Active Approach to Disruptive Tech
Disruptive technology is manifesting in heavier use of artificial intelligence (AI), machine learning, robotics, and other advancements. This is creating the need to adjust regulations at the federal and state levels.
FDTX: Disruptive Tech With Global Exposure
FDTX invests in companies leading tech advances, focusing on automation, AI, cybersecurity, and cloud computing, with a global portfolio and 80% asset allocation to disruptive tech. The fund's active management and worldwide strategy aim to capture growth opportunities and mitigate country-specific risks, though it carries high risk due to concentrated holdings. Compared to ARK Innovation ETF, FDTX has weakened recently but could reverse; its 0.50% fee aligns with other managed thematic ETFs.
